Vaginal microbicides.

Adolesc Med Clin

Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, Tufts University School of Medicine, The Floating Hospital for Children at Tufts-New England Medical Center, Boston, MA 02111, USA.

Published: October 2006

This article reviews the current status of microbicide development and challenges faced in developing safe and effective compounds. The ever growing HIV pandemic, lack of effective vaccines against HIV and other sexually transmitted infections, concern about the vulnerability of women, and difficulty in condom negotiation are factors that drive the development of topical microbicides as a prophylactic method for women. The ideal microbicide needs to be safe and highly effective and not increase viral resistance or cause disruption of host defenses. Advances in the understanding of HIV transmission and the role of other sexually transmitted infections have allowed progress in development of microbicide candidates as clinical trials of potential agents are awaited.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.admecli.2006.06.004DOI Listing

Publication Analysis

Top Keywords

sexually transmitted
8
transmitted infections
8
vaginal microbicides
4
microbicides article
4
article reviews
4
reviews current
4
current status
4
status microbicide
4
microbicide development
4
development challenges
4

Similar Publications

Taylorella equigenitalis is the causative agent of sexually transmitted contagious equine metritis. Infections manifest as cervicitis, vaginitis and endometritis and cause temporary infertility and miscarriages of mares. While previous studies have analyzed this organism for various parameters, the evolutionary dynamics of this pathogen, including the emergence of antibiotic resistance, remains unresolved.

View Article and Find Full Text PDF

The genus Neisseria includes two major human pathogens: N. meningitidis causing bacterial meningitis/septicemia and N. gonorrhoeae causing gonorrhoea.

View Article and Find Full Text PDF

Background: Tenofovir-containing antiretroviral therapy (ART) improves survival in HBV-coinfected people with HIV (PWH). We investigated the incidence of HDV infection and its clinical impact in HBV-coinfected PWH in the era of tenofovir-containing ART.

Methods: Between 2011 and 2022, HBV-coinfected PWH were included and followed until December 2023.

View Article and Find Full Text PDF

Addressing STIs through managed care: opportunities in Medicaid and beyond.

Am J Manag Care

December 2024

Department of Health Policy and Management, George Washington University School of Public Health, 950 New Hampshire Ave NW, Washington, DC 20037. Email:

The US is facing a growing epidemic of sexually transmitted infections (STIs), with over 2.5 million cases of chlamydia, gonorrhea, and syphilis reported in 2021 and again in 2022. This public health crisis disproportionately affects youth and racial and ethnic minority communities, exacerbating barriers to accessing sexual health services.

View Article and Find Full Text PDF

Purpose Of Review: Several microorganisms, which are not traditionally considered sexually transmitted infections (STIs), are capable of sexual transmission and have the potential to cause global outbreaks. The aim of this review is to describe pathogens which are not traditionally defined as STIs, to grant insight on current and potential outbreaks and call for clinical vigilance among members of key populations.

Recent Findings: Recent findings emphasize that several pathogens, not traditionally classified as STIs, can be sexually transmissible.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!